Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review

Jpn J Clin Oncol. 2004 Aug;34(8):457-62. doi: 10.1093/jjco/hyh076.

Abstract

Background: Breast cancer has emerged as one of the most frequent malignancies among Japanese women; however, the long-term survival of Japanese breast cancer patients is uncertain.

Methods: We analyzed the chronological changes in the clinical and pathological characteristics, treatment procedures and the long-term prognosis of 15 416 Japanese women with 16 217 primary breast cancers treated in the Cancer Institute Hospital in Tokyo between 1946 and 2001.

Results: Our analysis revealed a chronological increase in the mean patient age, postmenopausal patients and non-invasive carcinomas. Operative procedures became less extensive, with approximately 45% of breast cancer patients in 2000-2001 receiving breast-conserving treatment. Radiotherapy to the regional lymph nodes decreased, while postoperative chemotherapy and hormonal treatments have become more frequent. The survival rate has improved steadily during the past 5 decades. The 10-year crude overall survival rate improved from 61% before 1960 to 83% in the 1990s.

Conclusions: The survival rate of Japanese women with breast cancer has dramatically improved during the past 5 decades.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Breast Neoplasms / therapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Japan / epidemiology
  • Lymph Node Excision / statistics & numerical data
  • Lymphatic Metastasis
  • Mastectomy / methods
  • Mastectomy / statistics & numerical data*
  • Menopause
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Survival Rate
  • Time Factors

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal